Abdullah, Hilmi (2017) The use of febuxostat for gout in Hospital Tengku Ampuan Afzan (HTAA) Kuantan. In: Medical Research Symposium 2017, 10th August 2017, Kuantan, Pahang.
|
PDF
- Published Version
Download (91kB) | Preview |
Abstract
Febuxostat is a non-purine-selective oral xanthine oxidase inhibitor drug, and is an alternative to Allopurinol to lower serum uric acid in gout patients. It is probably more effective than Allopurinol, however, its use is limited because of its cost and availability. Allopurinol has been the mainstay treatment for gout for about 50 years. However, its use has been associated with allergic reactions especially in patients with renal impairment.The objective of this study was to describe HTAA Rheumatology Unit experiences with Febuxostat in the management of gout.
| Item Type: | Conference or Workshop Item (Plenary Papers) |
|---|---|
| Additional Information: | 4443/58502 |
| Uncontrolled Keywords: | febuxostat, gout, Hospital Tengku Ampuan Afzan (HTAA) Kuantan |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine |
| Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): | Kulliyyah of Medicine > Department of Internal Medicine |
| Depositing User: | Dr Hilmi Abdullah |
| Date Deposited: | 25 Sep 2017 16:34 |
| Last Modified: | 25 Sep 2017 16:34 |
| URI: | http://irep.iium.edu.my/id/eprint/58502 |
Actions (login required)
 |
View Item |
Download Statistics
Download Statistics